Skip to main content
. 2012 Apr 12;5(6):914–920. doi: 10.1242/dmm.008995

Fig. 1.

Fig. 1.

Validation and characterization of the Tp53R270H/+Nkx3.1-Cre mouse. (A) Schematic representation of the targeting vector and the floxed allele following excision of the STOP cassette by Nkx3.1 Cre recombinase. The R270H mutation is located in exon 8 (marked as a star). (B) Congenic backcross onto FVB/NJ was performed to ensure a uniform strain background. Speed congenics (N3 through N5) produced a close to 100% FVB/NJ congenic mouse. (C) RT-PCR and sequencing analysis of laser capture microdissected PIN lesions confirmed that Nkx3.1-Cre-mediated deletion of the floxed STOP cassette resulted in prostate-specific expression of the p53 R270H mutation. (D) Well-developed PIN lesions were observed in Tp53R270H/+ Nkx3.1-Cre mice as early as 4 months and more than 60% of mice examined between 5 and 60 weeks developed grade 2 or higher PIN (n=16). Nkx3.1 haploinsufficient littermate mice (Nkx3.1-Cre; n=6), which did not express the Tp53 mutation, did not develop PIN even at 60 weeks (see Fig. 2).